RGDXQ (Response Genetics) Institutional Ownership: 0.05% (As of Jul. 09, 2026)


What is Response Genetics Institutional Ownership?

Response Genetics RGDXQ -98.00% Institutional Ownership is 0.05% as of Jul. 09, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Response Genetics's institutional ownership is 0.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Response Genetics's Insider Ownership is 12.88%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Response Genetics's Float Percentage Of Total Shares Outstanding is 3.18%.

Response Genetics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Response Genetics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Genetics Institutional Ownership Chart

Response Genetics Historical Data

The historical data trend for Response Genetics can be seen below:

2015-12-31 2016-01-31 2016-02-29 2016-03-31 2016-04-30 2016-05-31 2016-06-30 2016-07-31 2016-08-31 2016-09-30
Institutional Ownership 0.06 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05

Response Genetics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.05% mean?
Response Genetics (RGDXQ) has a Institutional Ownership of 0.05% as of Jul. 09, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Response Genetics and its competitors.
Is Response Genetics' Institutional Ownership too high?
Response Genetics' current Institutional Ownership is 0.05%.
How does Response Genetics' Institutional Ownership compare to PSID and GBSN?
Response Genetics' Institutional Ownership of 0.05% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Diagnostics & Research company?
A good Institutional Ownership depends on the Medical Diagnostics & Research industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Response Genetics and its competitors. Response Genetics's current Institutional Ownership is 0.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Response Genetics stock overvalued right now?
Response Genetics (RGDXQ) has a current Institutional Ownership of 0.05%. The current Institutional Ownership is 0.05%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Response Genetics (RGDXQ), the current Institutional Ownership is 0.05% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Response Genetics Business Description

Address 201 Route 17 North, 2nd Floor, Rutherford, NJ, USA, 07070
Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.